BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 24, 2020
View Archived Issues
Sorrento develops Covidtrap protein for potential prevention and treatment COVID-19
Read More
BET on BD1 for cancer, BD2 for inflammation
Read More
Recruiting NK cells to the antitumor battle
Read More
AnHeart receives clinical trial authorization for taletrectinib in China
Read More
European Commission approves intravenous formulation of Akynzeo
Read More
FDA approves phase III study of Actemra in patients with severe COVID-19 pneumonia
Read More
First-in-human study of PLN-1474 for the treatment of liver fibrosis
Read More
Phase I data for influenza vaccination with a high-density microarray patch
Read More
Phase II data presented for intratumoral tavokinogene telseplasmid in metastatic melanoma
Read More
Researchers identify lncRNA RPL34-AS1 as potential therapeutic target in esophageal cancer
Read More
Arena Pharmaceuticals patents S1P1 agonists
Read More
Antibody gene therapy with AAV8-VRC07 appears feasible in HIV patients
Read More
Birdie Biopharmaceuticals discloses new imidazoquinoline derivatives
Read More
Pipeline Therapeutics identifies muscarinic M1 receptor antagonists
Read More
Achillion Pharmaceuticals presents complement factor D inhibitors
Read More
New eiF4E inhibitors presented by Pic Therapeutics
Read More
Biomedical R&D takes hit as university labs, trials shut down due to COVID-19
Read More
New MAb increases the effects of PF4 in sepsis, stabilizing NETs and enhancing microbial entrapment
Read More
AveXis releases new data from phase I/II study of intrathecal AVXS-101 in SMA type 2
Read More
Milestone reports phase III topline data on at-home use of etripamil for PSVT
Read More
Ascentage doses first U.S. patient in global study of APG-2575 for relapsed/refractory CLL/SLL
Read More
Synthon studies ADC SYD-1875 in first-in-human study for locally advanced or metastatic cancer
Read More
14,15-DHET is a marker of doxorubicin-related cardiotoxicity
Read More
USP28 regulates deltaNp63 protein abundance in squamous cell carcinoma and can be a druggable target
Read More